Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
Rocky Mountain Cancer Centers RMCC
mi
from
Greenwood Village, CO
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
Rocky Mountain Cancer Centers RMCC
mi
from
Greenwood Village, CO
Click here to add this to my saved trials
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
University Cancer and Blood Center LLC
mi
from
Athens, GA
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
University Cancer and Blood Center LLC
mi
from
Athens, GA
Click here to add this to my saved trials
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
Moanalua Medical Center. Attn: Oncology Dept
mi
from
Honolulu, HI
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
Moanalua Medical Center. Attn: Oncology Dept
mi
from
Honolulu, HI
Click here to add this to my saved trials
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
Karmanos Cancer Institute Dept.of KarmanosCancerInst (5)
mi
from
Detroit, MI
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
Karmanos Cancer Institute Dept.of KarmanosCancerInst (5)
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
Memorial Sloan Kettering Cancer Center Dept. of MSKCC
mi
from
NY, NY
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
Memorial Sloan Kettering Cancer Center Dept. of MSKCC
mi
from
NY, NY
Click here to add this to my saved trials
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
Medical University of South Carolina -Hollings Cancer Center Med Univ SC
mi
from
Charleston, SC
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
Medical University of South Carolina -Hollings Cancer Center Med Univ SC
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
Sarah Cannon Research Institute SC - 3
mi
from
Chattanooga, TN
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
Sarah Cannon Research Institute SC - 3
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (4)
mi
from
Dallas, TX
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (4)
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
Deke Slayton Cancer Center Deke Slayton Cancer Center (2)
mi
from
Webster, TX
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
Deke Slayton Cancer Center Deke Slayton Cancer Center (2)
mi
from
Webster, TX
Click here to add this to my saved trials
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated:  11/5/2015
Novartis Investigative Site
mi
from
Rosario,
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies
Status: Enrolling
Updated: 11/5/2015
Novartis Investigative Site
mi
from
Rosario,
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Baptist Medical Center South
mi
from
Jacksonville, FL
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Baptist Medical Center South
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Columbia University
mi
from
New York, NY
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Faulkner Hospital
mi
from
Boston, MA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Faulkner Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Good Samaritan Hospital, San Jose
mi
from
San Jose, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Good Samaritan Hospital, San Jose
mi
from
San Jose, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Marin General Hospital
mi
from
Greenbrae, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Marin General Hospital
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Massachusetts General Hospital
mi
from
Boston, MA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Norton Healthcare Pavilion
mi
from
Louisville, KY
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Norton Healthcare Pavilion
mi
from
Louisville, KY
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Presbyterian Medical Center
mi
from
Charlotte, NC
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Presbyterian Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
South Nassau Communities Hospital
mi
from
Oceanside, NY
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
South Nassau Communities Hospital
mi
from
Oceanside, NY
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Susan Downey
mi
from
Los Angeles, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Susan Downey
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Sutter Healthcare-Sacramento
mi
from
Sacramento, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Sutter Healthcare-Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
University of California, Irvine Medical Center
mi
from
Orange, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
eSSe Plastic Surgery
mi
from
Fort Lauderdale, FL
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
eSSe Plastic Surgery
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Methodist Hospital
mi
from
Houston, TX
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
A Pilot Study of Irradiated HLA-Partially Matched Allogeneic Related Donor Lymphocytes for Patients With Selected Malignancies
Status: Enrolling
Updated:  11/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
A Pilot Study of Irradiated HLA-Partially Matched Allogeneic Related Donor Lymphocytes for Patients With Selected Malignancies
Status: Enrolling
Updated: 11/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
A Phase II Study to Evaluate the Efficacy, Safety, and Genomic Markers of Response of Capecitabine as NeoAdjuvant Therapy in Women With Newly Diagnosed Locally Advanced Breast Cancer
Status: Enrolling
Updated:  11/5/2015
University of Chicago
mi
from
Chicago, IL
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
A Phase II Study to Evaluate the Efficacy, Safety, and Genomic Markers of Response of Capecitabine as NeoAdjuvant Therapy in Women With Newly Diagnosed Locally Advanced Breast Cancer
Status: Enrolling
Updated: 11/5/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
A Phase II Study to Evaluate the Efficacy, Safety, and Genomic Markers of Response of Capecitabine as NeoAdjuvant Therapy in Women With Newly Diagnosed Locally Advanced Breast Cancer
Status: Enrolling
Updated:  11/5/2015
University of Ibadan
mi
from
Ibadan,
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
A Phase II Study to Evaluate the Efficacy, Safety, and Genomic Markers of Response of Capecitabine as NeoAdjuvant Therapy in Women With Newly Diagnosed Locally Advanced Breast Cancer
Status: Enrolling
Updated: 11/5/2015
University of Ibadan
mi
from
Ibadan,
Click here to add this to my saved trials
Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions
The Process and Outcomes of Treatment Decision-Making Communication Between Oncologists and Newly Diagnosed Female Breast-Cancer Patients
Status: Enrolling
Updated:  11/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions
The Process and Outcomes of Treatment Decision-Making Communication Between Oncologists and Newly Diagnosed Female Breast-Cancer Patients
Status: Enrolling
Updated: 11/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
Phase II Evaluation of Ifosfamide Plus Doxorubicin & Filgrastim Versus Gemcitabine Plus Docetaxel & Filgrastim in the Treatment of Localized Poor Prognosis Soft Tissue Sarcoma
Status: Enrolling
Updated:  11/6/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
Phase II Evaluation of Ifosfamide Plus Doxorubicin & Filgrastim Versus Gemcitabine Plus Docetaxel & Filgrastim in the Treatment of Localized Poor Prognosis Soft Tissue Sarcoma
Status: Enrolling
Updated: 11/6/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
Psychoeducation For BMT Caregivers: Biobehavioral Markers and Outcome
Status: Enrolling
Updated:  11/6/2015
University of Colorado Cancer Center at UC Health Sciences Center
mi
from
Aurora, CO
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
Psychoeducation For BMT Caregivers: Biobehavioral Markers and Outcome
Status: Enrolling
Updated: 11/6/2015
University of Colorado Cancer Center at UC Health Sciences Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
Psychoeducation For BMT Caregivers: Biobehavioral Markers and Outcome
Status: Enrolling
Updated:  11/6/2015
Presbyterian/St. Luke's Medical Center (PSLMC) - Denver Midtown
mi
from
Denver, CO
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
Psychoeducation For BMT Caregivers: Biobehavioral Markers and Outcome
Status: Enrolling
Updated: 11/6/2015
Presbyterian/St. Luke's Medical Center (PSLMC) - Denver Midtown
mi
from
Denver, CO
Click here to add this to my saved trials
Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Phase II Evaluation of Imiquimod, a Topical Toll-like Receptor 7 (TLR7) Agonist in Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Status: Enrolling
Updated:  11/6/2015
NYU Cancer Institute
mi
from
New York, NY
Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Phase II Evaluation of Imiquimod, a Topical Toll-like Receptor 7 (TLR7) Agonist in Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Status: Enrolling
Updated: 11/6/2015
NYU Cancer Institute
mi
from
New York, NY
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Northeast Arkansas Clinic
mi
from
Jonesboro, AR
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Northeast Arkansas Clinic
mi
from
Jonesboro, AR
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Florida Cancer Specialists
mi
from
Fort Myers, FL
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Florida Cancer Specialists
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Medical Oncology Associates of Augusta
mi
from
Augusta, GA
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Medical Oncology Associates of Augusta
mi
from
Augusta, GA
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Baptist Hospital East
mi
from
Louisville, KY
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Baptist Hospital East
mi
from
Louisville, KY
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Norton Cancer Institute
mi
from
Louisville, KY
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Norton Cancer Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Hematology Oncology Clinic, LLP
mi
from
Baton Rouge, LA
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Hematology Oncology Clinic, LLP
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
National Capital Clinical Research Consortium
mi
from
Bethesda, MD
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
National Capital Clinical Research Consortium
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Research Medical Center
mi
from
Kansas City, MO
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Research Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Oncology Hematology Care
mi
from
Cincinnati, OH
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Oncology Hematology Care
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
The Family Cancer Center
mi
from
Collierville, TN
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
The Family Cancer Center
mi
from
Collierville, TN
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Peninsula Cancer Institute
mi
from
Newport News, VA
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Peninsula Cancer Institute
mi
from
Newport News, VA
Click here to add this to my saved trials